✦ LIBER ✦

Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER (+) breast cancer

✍ Scribed by Napoli, Nicola; Rastelli, Antonella; Ma, Cynthia; Yarramaneni, Jayasree; Vattikutti, Swapna; Moskowitz, Gerard; Giri, Tusar; Mueller, Cheryl; Kulkarny, Vibhati; Qualls, Clifford; Ellis, Matthew; Armamento-Villareal, Reina

Book ID: 121889973
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 274 KB
Volume: 55
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2013.04.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2007 POSTER Recommendations for the prev

2007 POSTER Recommendations for the prevention of aromatase inhibitor-associated bone loss in women with breast cancer

✍ M.S. Aapro; P. Hadji; A. Brufsky; M. Tubiana-Hulin; T. Guise; J.J. Body 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Effective inhibition of aromatase inhibi

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole : ZO-FAST study results

✍ Nigel J. Bundred; Ian D. Campbell; Neville Davidson; Richard H. DeBoer; Holger E 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract ## BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor‐positive early breast cancer, but long‐term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection the

Zoledronic acid (ZA) prevents aromatase

Zoledronic acid (ZA) prevents aromatase inhibitor (Al)-associated bone loss in postmenopausal women with early breast cancer -36-month follow-up of the Z-FAST study

✍ A. Brufskv; L. Bosserman; R. Caradonna; B. Haley; M. Jones; H. Moore; M. Dong; G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Immediate Administration of Zoledronic A

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

✍ Antonio Llombart; Antonio Frassoldati; Outi Paija; Harm Peter Sleeboom; Guy Jeru 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 437 KB

P153 An integrated analysis of zoledroni

P153 An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)

✍ A. Brufsky; N. Bundred; R. Coleman; R. Lambert-Falls; R. Mena; M. Dong; N. Schen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Loss of Retinoblastoma Gene (RB1) Is Ass

Loss of Retinoblastoma Gene (RB1) Is Associated with Deletions at the 17p13.3 Chromosome and S-Phase Index in Human Breast Cancer

✍ TIZIANA VENESIO; AMELIA BERNARDI; ANTONELLA SCORDAMAGLIA; PAOLO FERRERO; MONICA 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB